Ca’ Foscari is the only research institution in Italy to be selected for the “Marie Skłodowska-Curie - COFUND” project, a prestigious grant that will help the university hire 15 expert researchers from all over the world to tackle important global challenges.
Experimenting a targeted therapy innovative for ovarian cancer and developing a new drug for leiomyosarcoma are the ambitious objectives of two projects at the Ca' Foscari University of Venice, which will be supported by the AIRC Foundation.
The invention, jointly patented by the Ca' Foscari University and the IRCCS Cancer Institute in Aviano, will make it possible to optimise the doses administered according to the patient's response, limiting side effects and improving therapy.
The electrochemical sensor can measure the concentration of perfluorooctanesulfonate (PFOS), one of the most common and dangerous molecules in the PFAS family.
The kit makes it possible to grow organoids, i.e., miniaturised three-dimensional organs obtained from a few cells which can self-organise to reproduce the functions of the target organ. The development of organoids for research is considered one of the greatest scientific advances of recent years.
Mesoporous zirconium nanoparticles which can deliver diagnosis and cures for specific illnesses were synthesized and developed by researchers at Ca' Foscari sold a patent to a nanotech firm specialized in the chemical and pharmaceutical industry.
Transforming urban waste in bioplastic. This was the goal of scientists from four Italian universities including Ca’ Foscari in the research project Res Urbis (REsources from URban BIo-waSte) part of the Horizon 2020 program of the European Commission.
Fascinated by a class on the effectiveness of the bio cleaning of stones, Irene Scarpa developed and patented a new product for enzymatic cleaning. Tested at the Baths of Caracalla, it is already in demand from restorers.
A molecule developed and synthesized at Ca’ Foscari University of Venice has been made available to laboratories all over the world.